Alliance Fiber Optic Products (AFOP) - FREE Research Report Sun Ray Rei-Kung who is Director at Alliance Fiber Optic Products sold 1,000 shares at $15.68 on Nov. 8, 2013. Following this transaction, the Director owned 6,500 shares meaning that the stake was reduced by 13.33% with the 1,000 share transaction. The shares most recently traded at $16.03, up $0.35, or 2.21% since the insider transaction. Historical insider transactions for Alliance Fiber Optic Products go as follows:
4-Week # shares sold: 6,500
12-Week # shares sold: 548,500
24-Week # shares sold: 791,500
The average volume for Alliance Fiber Optic Products has been 1.1 million shares per day over the past 30 days. Alliance Fiber Optic Products has a market cap of $274.4 million and is part of the technology sector and electronics industry. Shares are up 151.91% year to date as of the close of trading on Friday. Alliance Fiber Optic Products, Inc. designs, manufactures, and markets various fiber optic components and integrated modules for communications equipment manufacturers and service providers in North America, Europe, and Asia. The stock currently has a dividend yield of 0.83%. The company has a P/E ratio of 15.6. Currently there are no analysts that rate Alliance Fiber Optic Products a buy, no analysts rate it a sell, and 1 rates it a hold. Exclusive Offer: Get the latest Stock Analysis on AFOP - FREETheStreet Quant Ratings rates Alliance Fiber Optic Products as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Alliance Fiber Optic Products Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.